In this review
Start with what leaves the household account
Semaglutide + B6 First Month Intro is listed at $99 for four weeks; tirzepatide + B6 is $149 for the same period, if prescribed. The cards call these one-time totals, with no automatic renewal. [1] DudeMeds treats the weekly equivalent as a comparison figure. Use the listed total when budgeting for the order. [5]
A clear first payment is useful. It still needs a defined medicine, supplied period and clinical decision. The promotional label does not establish that the same amount will buy every later order or that everyone is suitable for the advertised configuration.
The next order belongs in the comparison too
The product pages list eight-week Kickstart offers at $392 for semaglutide and $472 for tirzepatide. A cost estimate for continuing care needs the prices for later orders, which are separate from the Kickstart offers and still require patient questions and provider review. [2] [3] I would compare the expected next purchase before deciding that the opening order is affordable care over time.
These different supplies should not be forced into a single calendar-month rate. Ask what the clinician expects to review, which later offer could apply and what happens if the prescription changes. The household needs the likely cash timing without assuming a fixed automatic refill.
One-time billing is a commercial feature
Unlike the recurring subscription at SnagRx, DudeMeds describes a purchase that does not renew automatically. That lets you make a separate payment decision each time. If you compare Unique Physique’s default refills with a manual order, keep the payment decision separate from any discussion about continuing or changing treatment. The current process still leaves prescribing and instructions to the clinician. [1]
Coby Health offers an optional subscription, so check whether follow-up and ordering work differently if you choose recurring billing. With either provider, ask how to reach clinical help between orders. The product pages point existing patients toward the portal and say provider review still applies. [2] [3] Access to an account is not, on its own, a guarantee of a particular response time or uninterrupted supply.
Keep the formulation and the limits visible
The named offers are compounded semaglutide + B6 and tirzepatide + B6, not every medicine sharing those ingredient names. They are not FDA-approved. [1] The opened formulation answer does not claim B6 improves weight loss, reduces nausea or establishes equivalence to an approved product. [3]
I would let the clinician explain the selected preparation and whether it is appropriate. A broader wellness goal should not turn a choice between products into an assumption that any convenient format gives the same result. No enrollment, treatment experience or personal outcome is claimed in this review.
Resolve the contract before relying on flexibility
The product cards say no automatic renewal, yet the general sale terms still discuss recurring plans, charging before dispatch and medication fees for a first three-month period. [2] [3] [4] I would ask for a written explanation of the terms applying to this particular one-time order.
The terms distinguish a rejected prescription request from an approved or dispensed order and restrict medication refunds. They also assign laboratory expenses to the patient in the lab section. [4] Confirm any required testing and other charges rather than treating the card as proof that every possible service is included. No broad refund guarantee follows from the one-time wording.
My value judgment is about the full practical arrangement
DudeMeds is a reasonable comparison if the household wants to review a defined purchase rather than accept automatic renewal. Its state exclusions and clinical assessment still limit access; the current offers exclude Alabama, Arkansas, California, Kentucky and South Carolina. [1]
I would decide after the complete order and continuing-care plan are understood. Compare another provider over the same supplied period, with its care and testing charges attached. A useful purchase should remain understandable after the introductory offer has ended.
Understanding the cost
Semaglutide + B6 First Month Intro $99 one-time for four weeks; tirzepatide + B6 First Month Intro $149 one-time for four weeks, if prescribed. Eight-week Kickstart offers $392/$472 respectively. These are different one-time offers, not ongoing monthly rates; weekly equivalents are not weekly billing. General sale terms still contain recurring and three-month clauses; confirm the actual selected agreement and any additional charges. [1] [2] [3] [4]
Build your cost estimateSources
- DudeMeds current weight-care menu: one-time introductory offers and state exclusions
- DudeMeds semaglutide plus B6 Kickstart: eight-week total and continuation terms
- DudeMeds tirzepatide plus B6: one-time totals, supply periods and opened B6 qualification
- DudeMeds terms of sale, effective January 1, 2024: prescription charging, general recurring terms and refund conditions
- DudeMeds billing help: opened supply-duration versus subscription answer
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.